Trexquant Investment’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,946
Closed -$1.34M 1655
2020
Q2
$1.34M Buy
+10,946
New +$1.24M 0.09% 308
2020
Q1
Sell
-5,322
Closed -$556K 1557
2019
Q4
$556K Buy
+5,322
New +$597K 0.03% 524
2019
Q2
Sell
-11,735
Closed -$1.98M 1261
2019
Q1
$1.98M Sell
11,735
-14,639
-56% -$2.18M 0.14% 215
2018
Q4
$2.57M Buy
+26,374
New +$3.46M 0.16% 181
2017
Q1
Sell
-4,445
Closed -$497K 1412
2016
Q4
$497K Buy
+4,445
New +$535K 0.08% 442
2016
Q2
Sell
-12,643
Closed -$912K 1196
2016
Q1
$912K Sell
12,643
-11,076
-47% -$608K 0.11% 324
2015
Q4
$1.65M Buy
23,719
+15,509
+189% +$1.26M 0.15% 213
2015
Q3
$750K Buy
+8,210
New +$913K 0.06% 549

Other funds holding GWPH

Trexquant Investment's GWPH Position: Q3 2020 in Review

Trexquant Investment sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 10,946 shares — an estimated $1.34M sold.

Trexquant Investment first reported a position in GWPH in Q3 2015 and held it in 8 quarters. The position peaked at $2.57M in Q4 2018. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • Trexquant Investment reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Trexquant Investment sold 10,946 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $1.34M.
  • Trexquant Investment first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 8 quarters.
  • Trexquant Investment's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.57M in Q4 2018.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Trexquant Investment's 13F filing for Q3 2020, filed 6 Nov 2020.